BioCentury
ARTICLE | Clinical News

MaterniT21 PLUS laboratory-developed test regulatory update

October 29, 2012 7:00 AM UTC

The not-for-profit California Technology Assessment Forum (CTAF) recommended use of Sequenom's MaterniT21 PLUS laboratory-developed test (LDT) to detect prenatal fetal chromosomal anomalies. Specifica...